Resource Utilization and Costs of Stroke Unit Care in Germany  by Dodel, Richard C. et al.
Volume 7 • Number 2 • 2004
V A L U E  I N  H E A L T H
© ISPOR 1098-3015/03/$15.00/144 144–152 144
Blackwell Science, LtdOxford, UKVHEValue in Health1098-30152004 ISPORMarch/April 200472144152Original ArticleResource Utilization and Costs of  Stroke Unit Care in GermanyDodel et al.
Address correspondence to: Richard Dodel, Department of
Neurology, Friedrich-Wilhelms University, Bonn, Sigmund-
Freud-Strasse 25, 53105 Bonn, Germany. E-mail:
richard.dodel@ukb.uni-bonn.de
Resource Utilization and Costs of Stroke Unit Care 
in Germany
Richard C. Dodel, MD,1,2 Caroline Haacke, BSc,1 Karin Zamzow, BSc,1 Sven Pawelzik, BSc,1 
Annika Spottke, MD,1,2 Mira Rethfeldt, BSc,1 Uwe Siebert, MD, MPH, MSc,3 Wolfgang H. Oertel, MD,1 
Oliver Schöffski, PhD, MPH,4 Tobias Back, MD1
1Department of Neurology and Institute of Medical Biometry and Epidemiology, Philipps-University, Marburg, Marburg, Germany; 
2Department of Neurology, Friedrich-Wilhelms University, Bonn, Germany; 3Harvard Center for Risk Analysis, Harvard School of Public 
Health and Institute for Technology Assessment and Department of Radiology, Massachusetts General Hospital, Harvard Medical 
School, Boston, MA, USA; 4Chair for Health Management, Friedrich-Alexander University, Erlangen-Nuremberg, Germany
ABSTRACT
Objectives: Stroke imposes a considerable economic bur-
den on the individual and society. Recently, the concept of
an integrated stroke unit has been established in several
countries to improve the outcome of patients. This study
evaluates the costs of acute care of the different cerebro-
vascular insults in a stroke unit.
Methods: The study population included 340 patients
who were consecutively admitted to the Department of
Neurology, Philipps University Marburg, with the diag-
nosis of stroke or transient ischemic attack (TIA) between
January 1 and June 30, 2000. Clinical status and course
were evaluated by using the Barthel index and the modi-
ﬁed Rankin scale. Employing a “bottom-up” approach,
we calculated the costs from the perspective of the hospi-
tal and the third-party payer using data from provider
departments and other published sources.
Results: Inpatient costs were €3020 (US$3290) for TIA,
€3480 (US$3790) for ischemic stroke (IS), and €5080
(US-$5540) for intracerebral hemorrhage (ICH) and dif-
fered signiﬁcantly among these subgroups (P < .05).
Patient subgroups ranked in the same order for aver-
age length of stay at 9.4 days for TIA, 10.2 days for IS,
and 11.9 days for ICH (P > .05). Approximately 30%
of the hospital costs are due to physician charges and
care. Imaging amounted to 10% and lab investigations
to 14% of total costs, independent of the diagnosis.
Postacute treatment, including inpatient rehabilitation,
cost €9880 per patient. Across all diagnostic groups,
a mean clinical improvement was observed at time of
discharge.
Conclusions: Care of patients with cerebrovascular
events in a stroke unit causes a high demand of resources
and has a considerable impact on health-care expendi-
ture. Therefore, investigations comparing the stroke unit
concept with other strategies in stroke care are necessary
to evaluate the stroke unit concept for a rational use
of available resources in patients with cerebrovascular
events.
Keywords: cost, health-care utilization, stroke, stroke
unit, TIA.
Introduction
In developed countries, stroke is the third most
common cause of death after heart diseases and
cancer [1]. The incidence of stroke is highly age-
dependent and increases from 3 in 100,000 in the
third and fourth decade of life to 3,000 in 100,000
in the eighth and ninth decades [2]. In addition,
stroke is the leading cause of severe handicap,
dependency, and loss of social competence. It is esti-
mated that stroke is responsible for about 4% of the
total health-care costs [3–5].
In the past decade, there have been considerable
advances in the treatment options available to
stroke patients. These include new drugs, surgical,
and interventional treatments, as well as recanaliz-
ing therapies using thrombolytic agents. Advances
in imaging technology such as MR diffusion imag-
ing, MR angiography, and transesophageal echocar-
diography aid in the evaluation of stroke patients.
Recently, the concept of a specialized unit of care,
so-called stroke units, was established in different
countries to improve early care following stroke.
Stroke units are hospital-based wards that aim to
provide optimal and timely care by a specialized
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team for patients in the acute phase of stroke.
Stroke units have the advantage of offering greater
diagnostic accuracy, a standardized approach to
stroke, and appropriate monitoring and therapy [6–
8]. Analyses of stroke units have shown that severe
event rates, death, or severe disability, are substan-
tially reduced in patients treated in such units com-
pared to control groups for patients in both the
acute stage of stroke and the long term [8–10]. Bet-
ter outcomes come with increased costs, as the
treatment in stroke units generally requires more
personnel, monitoring devices, intensive care, etc.
Only a few studies have evaluated the costs of the
treatment of cerebrovascular events in a stroke unit
[10–14], data that are needed to allocate health-care
resources in an efﬁcient way.
The aim of this study is to estimate the cost of
inpatient care, length of hospital care, and treat-
ment patterns for patients suffering from cerebro-
vascular insults including transient ischemic attack
(TIA), ischemic cerebral infarction, and intracere-
bral hemorrhage (ICH) treated in a German hospi-
tal with an integrated stroke unit/intensive care
concept.
Costs were analyzed from the health-care pro-
vider’s (hospital’s) perspective because the reim-
bursements by the health-care payers (statutory
health insurance, “Krankenkassen”) do not neces-
sarily reﬂect the actual resource utilization. In Ger-
many, 99.8% of the population is covered by health
insurance, statutory or private, that would pay in
case of hospitalization on the basis of ﬁxed charges
per hospital-day (“Tagespﬂegesatz”) that may vary
between hospitals and even different wards of the
same hospital, for example, neurologic ward and
stroke unit daily charges. In light of the introduc-
tion of German diagnosis-related groups (DRG) in
2004, the estimation of resource utilization of
major diseases seems to be of particular importance.
Patient Selection and Methods
All patients who were admitted with the diagnosis
of stroke or TIA to the Department of Neurology,
Philipps-University Marburg, during the 6-month
period of January 1 to June 30, 2000 (n = 340),
were included in this study. Twenty-four patients
were excluded from the analysis, because their clin-
ical records were incomplete. Two patients did not
fulﬁll the diagnostic criteria and were excluded.
Eight patients were readmitted to the Department
of Neurology during the study period and both
inpatient periods were evaluated according to the
suggestions of a recent study [15].
Clinical Evaluation
A thorough medical history was obtained for each
patient, along with a complete medical and neuro-
logic examination based on a standardized diagnos-
tic procedure, which is part of the quality assurance
of stroke units in Hessen [16]. The clinical status
was rated using the Barthel index and modiﬁed
Rankin scale [17,18].
The diagnosis was based on clinical signs and
symptoms, as well as on the results from imaging
procedures (cCT; cMRI). The diagnosis according
to ICD-10 criteria at the time of discharge was used
to classify patients into three diagnostic groups:
TIA, ischemic stroke (IS), and ICH. In addition, the
following criteria were considered: affected side,
anterior/posterior circulation, and brain stem.
Economic Evaluation
Costs of treatment were considered adopting 1) the
perspective of the health-care provider (hospital)
and 2) the perspective of the health-care payer. The
latter are not presented in this article.
Perspective of the Hospital Direct medical costs
included costs for diagnostic procedures, medical
treatment, drugs, physiotherapy, speech therapy, and
nursing. The costs for nonmedical supplies and other
sundries were added based on a daily base charge
provided by the Department of Controlling and
Management of the Philipps-University Marburg.
Diagnostic Costs All diagnostic procedures during
the inpatient stay were included in the cost calcula-
tions. Prices were derived as a proxy from the ofﬁ-
cial tariff list of 2001 (GOÄ), which was still valid
at the evaluation period of this study [19].
Physicians The prices for the different medical pro-
cedures performed during the inpatient stay were
also taken from the GOÄ [19]. Costs of several of
the physicians’ tasks are not enclosed in the GOÄ,
for example, ward rounds, insertion of a venous
cannula, physical and neurologic examination of
patients, etc. These costs were determined by a 1-
week documentation of the allotment to complete
the different daily tasks. The mean time span for
each procedure was calculated and multiplied by
the hourly wages of a neurologist at the Department
of Neurology of the Philipps-University Marburg
(data provided by the Department of Controlling
and Management of the Philipps-University
Marburg.)
Drugs The 2002 prices of the drugs were provided
by the pharmacy of the Philipps-University,
Marburg.
Dodel et al.146
Additional Medical Costs The costs of physiother-
apy and speech therapy were based on the hourly
wage of a physiotherapist or logopedist in the
department.
Nursing Care Costs for nursing care were deter-
mined in a similar fashion as described for physi-
cians. The nurses documented the time needed for
all care activities for seven consecutive 24-hour
days. The mean time for each procedure was calcu-
lated and multiplied by the hourly wages of a nurse
in the department.
Care Resources Costs of the supplies for the wards
used for medical and nursing care was derived from
the annual list of supplies. We divided the annual
costs of the intensive care unit and the stroke unit
by 365 days and by the number of beds existing on
the wards, discounting the number of beds not
occupied in the period investigated.
Nonmedical Care The costs of the nonmedical serv-
ices, such as food, cleaning, heating, laundry, water,
and electricity, were included by using a daily base
charge (data provided by the Department of Con-
trolling and Management of the Philipps-University
Marburg).
Statistical Analysis
The data in the text are expressed as mean with
standard deviation and median with range. For
group comparisons and identiﬁcation of cost pre-
dictors, the Mann-Whitney U-test (two independent
groups), the Kruskal-Wallis test (more than two
independent groups) or the Wilcoxon rank test (two
dependent groups) was used. All tests were per-
formed as two-sided tests and P values < .05 were
regarded as statistically signiﬁcant. All analyses
were conducted with SPSS 10.0 for Windows
(2001, Chicago, IL), and SAS 8.0 for Windows
(2001, SAS Institute Inc., Cary, NC). Costs were
calculated in Euros (€) and reﬂect 2002 costs if not
stated otherwise. All costs were rounded to the
nearest of €10. In addition to Euros, all costs were
reported in US$ using the exchange rate 1€ = 1.09
US$.
Results
Clinical Data
A total of 314 patients with a mean age of
68.0 years (± 13.1 years) were included in the study.
Of these, 179 patients (57%) were diagnosed with
IS, 33 patients (10.5%) with ICH, and 102 patients
(32.5%) with TIA (Table 1). Age did not vary sta-
tistically between patients with different diagnoses
(P = .07; see Table 1). Women comprised 46.8% of
the total study population and 51.5% of the ICH
group, 47.5% of the IS group, and 44.1% of TIA
group. A total of 59.6% of patients were treated
primarily in the stroke unit; the others (40.4%)
were admitted initially to the neurologic ward or
intensive care unit. Time from symptom onset until
admission to the hospital was not different in the
disease groups (P > .05; see Table 2). Nevertheless,
only 50.2% of all patients were admitted to the hos-
pital within a 6-hour time frame. Twelve patients
died during the observation period (3.8%), 6 died
following ICH (18.2% of ICH cohort), and 6 died
following IS (3.4% of IS cohort). According to the
Barthel index and modiﬁed Rankin scale, evaluated
within the initial 24 hours after admission and
on the day of discharge, there was a signiﬁcant
improvement in mean values for the total cohort
comprising all cerebrovascular insults (P < .01,
Table 1). Clinical improvement could be docu-
mented for all diagnostic groups except patients in
the ICH group, which showed signiﬁcant improve-
ment in the Barthel index scores (P < .05), but not in
the Rankin scores during the evaluated period
(Table 1).
Table 3 shows the length of the inpatient stay in
different wards and for different clinical diagnoses.
Total duration of the inpatient stay ranged from 1
to 30 days with a median of 10 days. On average,
patients spent 2.1 ± 2.7 days in the stroke unit
Table 1 Age and outcome of  patients
Diagnosis
All: mean age
(years) ± SD (n)
Barthel Index
on day 1*
Barthel Index
at discharge*
Rankin score
on day 1*
Rankin score
at discharge*
TIA 66.7 ± 13.2 (102) 91.1 ± 18.8 (100) 96.1 ± 13.8‡ (100) 1.5 ± 1.3 (1) 0.6 ± 1.1‡ (0)
IS 68.6 ± 13.3 (179) 59.8 ± 33.9 (60) 71.5 ± 33.8‡ (90) 3.1 ± 1.3 (3) 2.4 ± 1.7‡ (2)
ICH 69.8 ± 10.5 (33) 28.0 ± 29.7 (25) 37.0 ± 39.4† (25) 4.2 ± 0.9 (4) 3.9 ± 1.0 (4)
Total 68.0 ± 13.1 (314) 66.6 ± 35.2 (80) 75.8 ± 34.2‡ (100) 2.7 ± 1.6 (3) 2.0 ± 1.8‡ (1)
*Mean ±  SD (median).
†Difference at P < .05 to corresponding value on day 1.
‡Difference at P < .01 to corresponding value on day 1.
Abbreviations: ICH, intracerebral hemorrhage; IS, ischemic stroke; TIA, transient ischemic attack.
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(range, 0–16 days), 1.0 ± 3.2 days, in the ICU and
6.9 ± 5.8 days in the regular ward. This reﬂects the
main goal of the stroke unit, which is to observe the
patients during the critical ﬁrst 24 to 48 hours fol-
lowing admission.
Inpatient Stay The average length of stay (LOS) was
9.4 ± 5.2 days (median, 8 days) for TIA, 10.2 ± 5.3
days (median, 10 days) for IS, and 11.9 ± 6.0 days
(median, 13 days) for ICH. The differences were not
signiﬁcant (P = .052) (Table 3). The mean LOS on
the stroke unit as determined only for those patients
who were primarily admitted to this unit (n = 187;
59.6%) amounted to 3.5 ± 2.6 days (median, 3
days).
Cost of Treatment (Perspective of the Hospital)
The total median costs per admission, independent
of the diagnosis, ranged from €490 to €15670 with
a median of €3030. Considering diagnosis-speciﬁc
costs per admission, a clear and statistically signif-
icant difference in ranking was observed. On aver-
age, patients with ICH were the most costly
(€5080), followed by IS (€3480) and TIA (€3020)
(P < .05 for all comparisons, Table 3). Average costs
in the ICH group were 1.68 times that for TIA and
1.46 times that for IS.
Costs of Diagnostic/Therapeutic Services and
Nursing In addition to the costs of hospitalization,
we calculated the costs of diagnostic procedures,
medical and nursing care, and drugs for the differ-
ent clinical diagnoses. Table 4 lists the costs for
inpatients differentiated into the several subgroups
of charges.
The highest costs of the subgroups of the inpa-
tient costs were caused by the daily base charge and
the physicians’ working hours (Table 4). Physicians’
work resulted in mean costs of €640 ± 320 per
inpatient stay. The mean costs of the TIA group
amounted €590 (19.5%), €640 (18.4%) for the IS
group, and €740 (14.6%) for the ICH group. These
differences were not signiﬁcant.
Nursing care amounted to mean costs of
€410 ± €390, with signiﬁcant differences between
the various clinical diagnoses: care for patients with
TIA (€280 ± €240) consumed less time than care
for patients with IS (€410 ± €330) and ICH
(€830 ± €660) (P < .01 for each). The duration of
hospitalization in IS patients was 1.1 times that for
TIA, but the difference in costs for nursing care was
1.5-fold higher (P < .01). Likewise, patients with
ICH were twice as costly than patients with IS
(P < .01), but had only 1.2 times longer stays in the
Table 2 Time interval to admission, mortality, and location of  discharge depending on the clinical diagnosis
Diagnosis
Interval (hours) from  
symptom onset until
admission (mean ± SD)
Inpatient
mortality (%)
Discharge to
home (%)
Nursing
home (%) Surgery (%) Rehabilitation (%) Others* (%)
TIA (n = 102) 24.3 ± 64.3 0 (n = 0) 83.3 (n = 85) 1.0 (n = 1) 1.0 (n = 1) 6.9 (n = 7) 7.8 (n = 8)
IS (n = 179) 28.8 ± 51.4 3.4 (n = 6) 34.6 (n = 62) 1.7 (n = 3) 4.4 (n = 8) 40.8 (n = 73) 15.1 (n = 27)
ICH (n = 33) 33.6 ± 92.9 18.2 (n = 6) 3.0 (n = 1) 3.0 (n = 1) 3.0 (n = 1) 66.7 (n = 22) 6.1 (n = 2)
Total (n = 314) 27.8 ± 60.5 3.8 (n = 12) 47.1 (n = 148) 1.6 (n = 5) 3.2 (n = 10) 32.5 (n = 102) 11.8 (n = 37)
*Those patients have been referred to other hospitals such as departments of  internal medicine or other neurologic hospitals.
Abbreviations: ICH, intracerebral hemorrhage; IS, ischemic stroke; TIA, transient ischemic attack.
Table 3 Length of  hospital stay (LOS) in days and inpatient costs in €
Diagnosis
Total LOS
(days)
Days in
stroke unit
Days in intensive
care unit
Days in
regular ward
Costs per
admission (€)
Costs per
day (€)
TIA
Mean (± SD) 9.4 ± 5.2 1.8 ± 2.2† 0.3 ± 2.2†,‡ 7.2 ± 5.6 3,020 ± 1,790* 340 ± 90†
Median (range) 8 (2–25) 1 (0–9) 0 (0–22) 7 (0–23) 2,710 (730–14,060) 320 (240–640)
IS
Mean (± SD) 10.2 ± 5.3 2.5 ± 2.9† 0.6 ± 2.6† 7.0 ± 5.6 3,480 ± 1,870† 360 ± 110†
Median (range) 10 (1–30) 2 (0–16) 0 (0–19) 7 (0–30) 3,070 (490–15,240) 330 (230–920)
ICH
Mean (± SD) 11.9 ± 6.0 1.1 ± 2.4 5.4 ± 4.8 5.4 ± 6.8 5,080 ± 2,900 490 ± 300
Median (range) 13 (1–30) 0 (0–11) 5 (0–16) 4 (0–30) 5,070 (680–15,670) 460 (240–1970)
Total
Mean (± SD) 10.1 ± 5.4 2.1 ± 2.7 1.0 ± 3.2 6.9 ± 5.8 3,500 ± 2,060 370 ± 140
Median (range) 10 (1–30) 1 (0–16) 0 (0–22) 7 (0–30) 3,030 (490–15,670) 340 (230–1970)
*Different at P < .01 from IS and ICH groups.
†Different at P < .01 from ICH group (P < .01).
‡Different at P < .05 from IS group (P < .05).
Abbreviations: ICH, intracerebral hemorrhage; IS, ischemic stroke; TIA, transient ischemic attack.
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hospital. This indicates that nursing time spent per
patient is higher for ICH patients than for IS
patients and, in turn, higher for IS patients than
for TIA patients. Furthermore, the costs for speech
therapy and physiotherapy made up only 1 to 2%
of the total costs (TIA, 1.0%; IS, 1.7%; ICH,
1.8%).
Average lab analysis and imaging costs ranged
between €510 and €340 and were among the most
expensive components of the care for stroke
patients. Interestingly, costs for drug therapy were
low in our study population, resulting in mean
total costs of €120 ± €240. Although TIA and IS
caused average drug costs of €70 and €90, costs for
the treatment of ICH were considerably higher
at €450 ± €470 (p < .05). During the observation
period, however, no acute lysis therapy was per-
formed for the treatment of IS. The laboratory anal-
ysis costs amounted to €440 for the TIA and to
€520 for the IS group compared to €690 for the
ICH group (P < .05 vs. TIA group). With regard to
imaging, there were no differences in costs among
the different diseases. In the TIA group, the total
incidence of MRI scans was higher than in ICH
patients; however, the number of consecutive cCT
scans was higher in the ICH group.
Predictors of Costs To investigate the inﬂuence of
age on costs of cerebrovascular events, we catego-
rized the patients in age groups based on their age
on the day of admission (<50 years of age, 50–59
years, 60–69 years, ≥70 years). No age-dependent
differences in LOS or costs were found (mean LOS,
<50 years, 10.6 ± 6.0 days; 50–59 years, 10.6 ± 5.6
days; 60–69 years, 10.7 ± 5.4 days; ≥70 years,
9.5 ± 5.1 days; mean costs, <50 years,
€5080 ± €2800;  50–59  years,  €4720 ± €2840;
60–69 years, €4960 ± €2220; ≥70 years,
€4450 ± €2970) (P > .05 for each).
There was no statistical difference in costs
between right- or left-sided cerebrovascular events,
nor was there a difference regarding the territory of
the stroke, anterior or middle cerebral artery. Fur-
thermore, costs and LOS for acute treatment did
not differ signiﬁcantly between patients who suf-
fered from anterior versus posterior cerebral circu-
lation disorders. The same ﬁnding was observed
when only the IS and ICH groups were selected.
Costs per admission were higher in disabled
patients with Rankin scores of 3 to 6 at discharge
(€4030 ± €2780) compared with nondisabled pa-
tients having Rankin scores of 0 to 2 (€3160 ±
€1300; P < .05) (Table 5). The calculation of costs
stratiﬁed on Barthel index showed a trend towardTa
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more costly treatment with increasing clinical sever-
ity at discharge, but it did not reach statistical sig-
niﬁcance (Table 5).
Poststroke Treatment Following diagnosis and
acute care in the university hospital setting, patients
were subsequently (Table 2) discharged to home
(47.1%), sent to a rehabilitation clinic (32.5%),
transported to another hospital (11.8%), under-
went endarterectomy (TEA) (3.2%), or discharged
to a nursing home (1.6%). Mean costs for postacute
inpatient treatment were €9880 ± TEA 8230 (mean
LOS, 35.4 ± 29.5 days; median LOS, 28 days;
range, 0–183 days). The latter costs were estimated
on the basis of daily hospital charges (“Tagesp-
ﬂegesatz”).
On day 1 after admission, 66% of patients with
IS and more than 94% of patients with ICH were
handicapped, having Rankin scores of 3 to 6. Severe
disability was present in 24% of IS patients and
55% of ICH patients, with Barthel index scores
of less than 30. At discharge, the percentage of
patients with Rankin scores of 3 to 6 had decreased
to 47% (IS group) and to 88% (ICH group); the
percentage of patients with Barthel index scores of
less than 30 had declined to 15.1% (IS group), but
remained rather constant (54.5%) in the ICH
group. Discharge to home accounted for 83.3% of
patients with TIA, 34.6% with IS, and 3% of the
ICH group. Discharge to a rehabilitation clinic
accounted for 6.9% in the TIA group, 40.8% in the
IS group, and 66.7% in the ICH group. Approxi-
mately 2% of the IS group and TIA group under-
went endarterectomy.
Discussion
In this study, we assessed the burden of the acute
care of cerebrovascular events including TIA, IS,
and ICH in a German university hospital setting.
The total direct medical costs amounted to a mean
of €3500 ± €2060 per admission. Treatment of
patients with TIA was signiﬁcantly less costly, at
€3020 ± €1790, than the treatment of IS at €3480
and ICH at €5080. Inpatient mortality was low
among patients with IS (3.4%) and ICH (18.2%),
which is lower than in a US study in which 7.0%
died owing to IS and 33.1% owing to ICH.
In our study, LOS was similar to that observed in
previously published studies [3]. We calculated a
mean LOS of 9.4 ± 5.2 days in patients with TIA,
10.2 ± 5.3 days in patients with IS, and 11.8 ± 6.0
days in patients with ICH. The average LOS in the
United States for patients with IS ranges from about
6 to 11 days, compared to 17 to 47 days in Canada,
Europe, and Asia [3,20–23].
Only a few studies that have assessed in detail the
costs owing to TIA are available [3,15,22–25].
Among these, LOS and cost vary considerably. In a
Danish study, the mean LOS was shorter compared
to our study, ranging from 1 to 17 days with a mean
of 4 days (median, 2 days) and resulting in costs
of Danish Kronen (DKr) 10,100 (€1840 or US$1800
[15]). Similar results from a Singapore study have
been reported with a mean LOS of 4 days resulting
in costs of €2000 (US$1962) [23]. Two US studies
reported mean inpatient costs for patients with TIA
of US$3350 and US$4653 with a mean LOS of 3.4
and 3.8 days, respectively [3,25]. Unfortunately, no
additional details are listed in the report. In Europe,
a study from Italy reported a median LOS of 8 days
(range, 1–21 days), which comes close to the LOS in
the current study [26]. Some proportion of the dif-
ference is surely due to the use of different method-
ologies to estimate costs, as well as to the different
health-care systems. Nevertheless, in our university
hospital setting, the routine workup of IS or TIA
patients includes a lab analysis, ECG, EEG, Doppler
ultrasound, and transesophageal echocardiography,
as well as an initial imaging, either cCT and cMRI,
for all patients with the diagnosis of a cerebrovas-
Table 5 Distribution, costs, and length of  stay (LOS) of
patients as determined by the stratiﬁed Rankin scale and Bar-
thel index (BI) at the time of  discharge
Stratiﬁed score Percentage
Costs per 
admission (€) LOS (days)
ICH (n = 33)
Rankin 0–2 12.1 4020 ± 1670 14.0 ± 2.9
Rankin 3–6 87.9 5230 ± 3030 11.6 ± 6.3
BI < 30 54.5 5470 ± 3310 10.9 ± 6.6
BI 30–70 15.2 4870 ± 3440 11.4 ± 7.8
BI > 70 30.3 4490 ± 1810 13.7 ± 3.4
IS (n = 179)
Rankin 0–2 53.1 3290 ± 1130 10.6 ± 4.4
Rankin 3–6 46.9 3700 ± 2440 9.8 ± 6.1
BI < 30 15.1 3740 ± 3040 8.4 ± 6.0
BI 30–70 25.1 3540 ± 2020 9.9 ± 5.6
BI > 70 59.8 3390 ± 1370 10.8 ± 4.9*
TIA (n = 102)
Rankin 0–2 90.2 2980 ± 1430 9.5 ± 5.1
Rankin 3–6 9.8 3340 ± 3890 8.1 ± 6.2
BI < 30 1.0 730 ± 0 2.0 ± 0
BI 30–70 4.9 4380 ± 5460 8.8 ± 7.7
BI > 70 94.1 2970 ± 1420 9.5 ± 5.1
Total (n = 314)
Rankin 0–2 60.8 3160 ± 1300 10.1 ± 4.8
Rankin 3–6 39.2 4030 ± 2780† 10.1 ± 6.2
BI < 30 14.6 4350 ± 3240 9.3 ± 6.3
BI 30–70 17.6 3730 ± 2570 9.9 ± 5.9
BI > 70 67.8 3250 ± 1450 10.4 ± 5.0
*Signiﬁcantly different from IS group with Barthel index scores <30 (p < .05).
†Signiﬁcantly different from total patient group with Rankin scores ranging from
0 to 2 (P < .05).
Abbreviations: ICH, intracerebral hemorrhage; IS, ischemic stroke; TIA, tran-
sient ischemic attack.
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cular event. This complete diagnostic workup
requires increased hospitalization time. In contrast,
in the Danish study only 47% of the patients had
cCT scans during the hospital stay or as outpatients,
and 45% had ECG and/or ultrasound of the carotid
arteries [15]. This may account at least in part
for the differences of LOS among these studies.
Whether certain diagnostic evaluations are neces-
sary to evaluate the cause or causes of TIA is still
under investigation. Currently, no studies are avail-
able that address the question whether higher costs
owing to more detailed assessment may be cost-
effective by preventing future strokes, thereby
reducing medical costs in the future.
Compared to the costs for TIA and IS, the
costs for ICH were signiﬁcantly higher in this
study. This ranking was also found in US and Sin-
gapore studies [3,23]. This robust increase in costs
after ICH is due to a prolonged stay and higher
health-care utilization.
We investigated several factors that may be pre-
dictors of increased expenses. As was observed in
earlier studies, neither age nor sex had an impact
on the cost of acute treatment (data not shown),
although age does inﬂuence the effectiveness of
stroke unit care [3,11]. In addition, we calculated
the costs depending on the affected side (left or
right; stroke owing affection of the vascular terri-
tory of A. cerebri anterior/A. cerebri media/A. cer-
ebri posterior). There was no signiﬁcant difference
in costs between right- or left-sided cerebrovascular
events, nor was there a difference depending on
the vascular territory. Large-vessel infarcts (whether
atherosclerotic or cardioembolic in origin) with an
extent greater than 50% of hemispheric volume was
more costly owing to prolonged inpatient stay than
IS or ICH with an affected volume of less 50% of
the cerebral hemisphere.
Interestingly, expenses for postacute treatment of
stroke were high and exceeded the acute care costs
as calculated in our setting. In our study population,
mean total costs of postacute care were €9880 for
patients in whom treatment was continued on an
inpatient basis, for example, at a rehabilitation
clinic. In our study, 49% of the patients were not
discharged to home but continued treatment in dif-
ferent settings (Table 2), which causes considerable
additional utilization of resources in Germany. To
date, no data from German clinical studies are
available, which would allow for comparison.
This study has several limitations. First, the study
addresses only direct medical costs. No indirect
costs (i.e., costs owing to lost productivity) have
been evaluated as outlined earlier. Nevertheless,
such investigations are under way. Second, the study
population included only patients admitted to a
neurologic service with a stroke unit. In Germany,
however, a distinct number of patients with stroke
are admitted to departments of general or internal
medicine that lack an integrated stroke unit. There-
fore, an extrapolation of the costs of this study as
total costs of stroke in Germany is limited. In addi-
tion, earlier studies have shown that there is a var-
iation in LOS and costs of stroke depending on the
hospital of admission (e.g., community hospital vs.
major teaching hospital) [3].
Third, the expenses owing to the postacute inpa-
tient stay are biased because we were not able to
calculate costs for the patients discharged to home.
There is an increased resource utilization and
increased time of caregiving for patients following
stroke, which is most often provided by relatives
[36]. In addition to high medical costs, indirect
costs (i.e., costs incurred for sickness beneﬁt, early
retirement, and death before the age of 65) make
up a considerable proportion of the total costs. In
several studies, indirect costs were calculated
between 8 and 58% of the total cost [11,27–30].
The American Heart Association estimated the
total cost of stroke in 1999 as US$45.3 billion, with
US$15.8 billion of that a result of loss of produc-
tivity associated with death or morbidity. A recent
review reported that 11 to 85% of patients are
working after stroke, depending on the study
design and the investigated country [31]. Unfortu-
nately, in our study we could not evaluate indirect
costs incurred by the different cerebrovascular
events owing to the study design. Nevertheless, we
hypothesize that indirect costs have a considerable
impact on the costs to society in Germany: 1)
approximately 25% of the patients in our study
were younger than 60 years of age; 2) stroke causes
severe handicap (approximately 57% of stroke
patients were severely handicapped following
stroke [32]); 3) there is a high incidence of comor-
bid diseases, such as cardiac and other vascular dis-
eases that may have an additional impact on annual
working hours and reduced lifetime working hours
in stroke patients; and 4) intangible costs owing to
stroke have not yet been evaluated. Nevertheless, as
all dimensions of health-related quality of life
including social functions and mental health are
considerably affected (e.g., poststroke depression) a
high impact can be expected concerning intangible
costs [33–35].
In conclusion, our data provide additional evi-
dence that stroke causes a high economic burden to
society [37]. This study supports prior ﬁndings
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regarding the variation of health-care utilization
depending on the cause of the cerebrovascular
event. Because of the magnitude of the differences,
we caution against the application of estimates from
analyses that do not differentiate between types of
cerebrovascular events, especially if data are used
for modeling of comparative studies, where long-
term effects are examined and the type or stage of
the disease must be considered.
Additional studies are necessary, including eco-
nomic appraisals of whether the concept of an
integrated stroke unit for the treatment of cere-
brovascular events merits the additional resource
utilization. A recent German health technology
report commissioned by the German Institute
for Medical Documentation and Information
(DIMDI) questioned the concept of stroke units
other than specialized units with early rehabilita-
tion [38]. Nevertheless, the economic as well as
the outcome data available make an evidence-
based conclusion in Germany as well as in other
European countries currently impossible.
The study was supported by the German Ministry of Edu-
cation and Research “Competence Network Parkinson-
Syndromes” Grant BMBF Nr. 01GI9901/1, and by the
Wicker Foundation, Bad Wildungen, Germany.
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